Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial with etoricoxib

BACKGROUND: Our objective was to evaluate the effect of background biological disease-modifying anti-rheumatic drugs (bDMARDs) and/or corticosteroids (CS) on response to nonsteroidal anti-inflammatory drugs (NSAIDs) in rheumatoid arthritis (RA) patients. METHODS: The following efficacy endpoints wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Kvien, Tore K, Greenwald, Maria, Peloso, Paul M, Wang, Hongwei, Mehta, Anish, Gammaitoni, Arnold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344787/
https://www.ncbi.nlm.nih.gov/pubmed/25886874
http://dx.doi.org/10.1186/s12891-015-0468-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344787/
https://www.ncbi.nlm.nih.gov/pubmed/25886874
http://dx.doi.org/10.1186/s12891-015-0468-7

Ejemplares similares